Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

AGILON HEALTH, INC.

(AGL)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Agilon Health : Prices Secondary Share Offering At $30 Per Share

09/10/2021 | 06:25am EDT


ę MT Newswires 2021
All news about AGILON HEALTH, INC.
04:32pagilon health to Participate in the Credit Suisse 30th Annual Virtual Healthcare Confer..
BU
10/20AGILON HEALTH : Jefferies Starts agilon health at Buy with $35 Price Target
MT
10/12AGILON HEALTH : Sets Date to Report Third Quarter 2021 Financial Results
BU
10/12Certain Common Stock of agilon health, inc. are subject to a Lock-Up Agreement Ending o..
CI
10/12Certain Stock Options of agilon health, inc. are subject to a Lock-Up Agreement Ending ..
CI
10/11THE BENEFITS OF VALUE-BASED CARE FOR : A Primary Care Physician Shares How She Serves Her ..
PU
10/07AGILON HEALTH : Names Chief People Officer
MT
10/07Agilon health, inc. Appoints Mat Vargehese as New Chief People Officer, Effective Octob..
CI
10/07AGILON HEALTH : Names Mat Varghese as New Chief People Officer
BU
10/07AGILON HEALTH : Zanesville Physician Recognized for Excellence in Senior Patient Care Hono..
PR
More news
Analyst Recommendations on AGILON HEALTH, INC.
More recommendations
Financials (USD)
Sales 2021 1 870 M - -
Net income 2021 -397 M - -
Net cash 2021 1 079 M - -
P/E ratio 2021 -23,7x
Yield 2021 -
Capitalization 9 299 M 9 299 M -
EV / Sales 2021 4,40x
EV / Sales 2022 3,16x
Nbr of Employees 550
Free-Float 98,5%
Chart AGILON HEALTH, INC.
Duration : Period :
agilon health, inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AGILON HEALTH, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Last Close Price 23,79 $
Average target price 39,89 $
Spread / Average Target 67,7%
EPS Revisions
Managers and Directors
Steven J. Sell President, Chief Executive Officer & Director
Timothy S. Bensley Chief Financial Officer
Ronald A. Williams Chairman
Benjamin Kornitzer Chief Medical & Quality Officer
Girish Venkatachaliah Chief Technology Officer
Sector and Competitors